Singapore: The European Commission (EC) is going to fine seven generic drug firms, including India-based Ranbaxy and Den...
Singapore: Regulatory hurdles continue to haunt Impax Laboratories and its experimental drug, Rytary, that treats idiopa...
Singapore: The US FDA provided its final approval to Indian drug maker Lupin to manufacture and market a generic version...
Singapore: India's Aurobindo Pharma has submitted an Abbreviated New Drug Application (ANDA) for dolutegravir 50mg, for ...
Singapore: Montreal-based generic drug developer and marketer Pharmascience is venturing into Korea by forming a joint v...
Singapore: Orexigen Therapeutics and Takeda Pharmaceuticals have filed a lawsuit in US against Actavis for filing an abb...
Singapore: The US Food and Drug Administration (FDA) has slapped a warning letter to China based Tianjin Zhongan Pharma...
Singapore: Beximco pharmaceuticals, a Bangladeshi pharma giant announced that it had received Good Manufacturing Practic...
Singapore: With the strategy to strengthen its pain management portfolio, global biopharmaceutical company, Teva Pharmac...
Singapore: Australian drug maker Mayne Pharma announced Mr Blake Cullen as the new vice president of business developmen...
Singapore: British drugmaker GlaxoSmithKline has approached the Foreign Investment Promotion Board (FIPB) to hike stake ...
India's pharma industry, mainly comprising generics has got a breather. The government in India has decided to cap brown...
Singapore: Addressing the global media for the first time after allegations were leveled out against Britain's largest d...
Mumbai: Lupin Phamaceuticals has received final approval for its Ranolazine extended-release tablets, 500 mg and 1000 mg...
Singapore: Eli Lilly has filed a $500 million international lawsuit against the Canadian government alleging that the co...
Singapore: Alchemia's commercialization partner Dr Reddy's Laboratories has launched Alchemia's FDA approved generic an...
Singapore: Pharma major Abbott Laboratories has unveiled its strategy for the Indian market, claiming that it will push ...
Singapore: Global pharma firm, Pfizer, plans to acquire InnoPharma at approx $360 million to strengthen its generics, in...
